Free Trial

U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Victory Capital Management Inc.

U.S. Physical Therapy logo with Medical background

Key Points

  • Victory Capital Management Inc. reduced its position in U.S. Physical Therapy, Inc. by 38.6%, owning 19,162 shares after selling 12,027 shares in the first quarter.
  • Analysts have mixed ratings for U.S. Physical Therapy, with a consensus average rating of "Moderate Buy" and a price target of $109.00.
  • The company announced a $0.45 quarterly dividend, representing a 2.40% yield, with a payout ratio of approximately 82.57%.
  • Want stock alerts on U.S. Physical Therapy? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Victory Capital Management Inc. reduced its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 38.6% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 19,162 shares of the company's stock after selling 12,027 shares during the quarter. Victory Capital Management Inc. owned about 0.13% of U.S. Physical Therapy worth $1,387,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. bought a new position in U.S. Physical Therapy during the fourth quarter worth about $39,000. Fifth Third Bancorp grew its position in U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock worth $75,000 after buying an additional 265 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in U.S. Physical Therapy during the fourth quarter worth approximately $84,000. Aquatic Capital Management LLC lifted its stake in U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after purchasing an additional 198 shares during the last quarter. Finally, First Horizon Advisors Inc. lifted its stake in U.S. Physical Therapy by 35.0% during the first quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company's stock worth $140,000 after purchasing an additional 500 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on USPH. JMP Securities restated a "market outperform" rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Barrington Research reiterated an "outperform" rating and set a $98.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, July 1st. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $109.00.

Read Our Latest Stock Report on U.S. Physical Therapy

U.S. Physical Therapy Trading Down 4.0%

NYSE USPH traded down $2.94 during trading on Friday, hitting $70.21. 151,519 shares of the company's stock traded hands, compared to its average volume of 180,628. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. The stock has a fifty day moving average of $76.20 and a two-hundred day moving average of $77.48. The firm has a market cap of $1.07 billion, a P/E ratio of 32.21, a PEG ratio of 3.39 and a beta of 1.45. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $101.19.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The company had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. During the same quarter last year, the firm earned $0.51 earnings per share. The firm's quarterly revenue was up 18.0% compared to the same quarter last year. As a group, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 23rd were given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the sale, the director directly owned 2,594 shares in the company, valued at approximately $202,357.94. The trade was a 13.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.00% of the stock is owned by insiders.

About U.S. Physical Therapy

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Articles

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines